TABLE 5.
Mean life span of strains overexpressing catalase and Cu/ZnSOD
Genotype | Life span (mean ± SEM) (days) of:
|
% Change (HP − Co)/Coa | P (HP versus Co) | |
---|---|---|---|---|
Co | HP | |||
Expt 1 | ||||
FLP1;CAT2A2;SOD3A1(D) | 53.64 ± 0.74 | 51.24 ± 0.68 | −4.48* | 0.0164 |
FLP1;CAT2B2;SOD3A1(D) | 52.93 ± 0.77 | 52.11 ± 0.72 | −1.56 | 0.4354 |
FLP1;CAT2B12;SOD3A1(D) | 51.13 ± 0.86 | 42.71 ± 0.70 | −16.47* | <0.0001 |
FLP1;CAT2A2;SOD3B2(D) | 52.46 ± 0.93 | 43.28 ± 0.87 | −17.50* | <0.0001 |
FLP1;CAT2B2;SOD3B2(D) | 54.19 ± 0.71 | 49.50 ± 0.66 | −8.66* | <0.0001 |
FLP1;CAT2B12;SOD3B2(D) | 62.86 ± 0.82 | 57.86 ± 0.63 | −6.82* | <0.0001 |
FLP1;CAT2A2;SOD3A1(T) | 30.53 ± 0.61 | 36.27 ± 0.65 | +18.80* | <0.0001 |
FLP1;CAT2B2;SOD3A1(T) | 36.11 ± 0.72 | 37.22 ± 0.77 | +3.09 | 0.2892 |
FLP1;CAT2B12;SOD3A1(T) | 34.16 ± 0.70 | 33.50 ± 0.60 | −1.93 | 0.4654 |
FLP1;CAT2A2;SOD3B2(T) | 34.95 ± 0.72 | 29.80 ± 0.71 | −14.72* | <0.0001 |
FLP1;CAT2B2;SOD3B2(T) | 41.06 ± 0.81 | 36.93 ± 0.59 | −10.06* | <0.0001 |
FLP1;CAT2B12;SOD3B2(T) | 40.29 ± 0.98 | 38.90 ± 0.88 | −3.45 | 0.2892 |
Expt 2 | ||||
FLP1;CAT2A2;SOD3A1(D) | 45.94 ± 0.69 | 47.84 ± 0.71 | +4.13 | 0.0548 |
FLP1;CAT2B2;SOD3A1(D) | 46.53 ± 0.58 | 50.41 ± 0.59 | +8.35* | <0.0001 |
FLP1;CAT2B12;SOD3A1(D) | 59.03 ± 0.76 | 56.80 ± 0.47 | −3.77* | 0.0132 |
FLP1;CAT2A2;SOD3B2(D) | 46.82 ± 0.75 | 40.99 ± 0.65 | −12.45* | <0.0001 |
FLP1;CAT2B2;SOD3B2(D) | 56.11 ± 0.90 | 51.16 ± 0.65 | −8.82* | <0.0001 |
FLP1;CAT2B12;SOD3B2(D) | 57.35 ± 0.78 | 59.07 ± 0.75 | +2.99 | 0.1118 |
FLP1;CAT2A2;SOD3A1(T) | 37.03 ± 0.77 | 36.63 ± 0.79 | −1.79 | 0.5418 |
FLP1;CAT2B2;SOD3A1(T) | 35.44 ± 0.69 | 37.33 ± 0.84 | +5.33 | 0.0818 |
FLP1;CAT2B12;SOD3A1(T) | 40.53 ± 0.96 | 38.55 ± 0.93 | −4.89 | 0.1362 |
FLP1;CAT2A2;SOD3B2(T) | 32.68 ± 0.76 | 30.09 ± 0.72 | −7.92* | 0.0136 |
FLP1;CAT2B2;SOD3B2(T) | 39.99 ± 1.12 | 39.84 ± 1.05 | −0.37 | 0.9204 |
FLP1;CAT2B12;SOD3B2(T) | 42.22 ± 0.98 | 46.68 ± 0.88 | +10.57* | 0.0020 |
∗, statistically significant change.